Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prevention of gestational diabetes in obese pregnant women
2018-000003-16Phase 4Unknown
- Sponsor
- King's College London
- Start
- Sep 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of metformin in gestational diabetes mellitus (GDM) (3 arms), sponsored by King's College London. Primary endpoint: Reduction in mean 24-hour glucose after 8 weeks. Status: unknown.
02
Drugs
metformin
03
Conditions
gestational diabetes mellitus (GDM)
Beyond the preview
Go deeper on 2018-000003-16.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2018-000003-16.